Medicus Pharma (MDCX) Retained Earnings (2023 - 2025)

Medicus Pharma (MDCX) reported Retained Earnings of -$64.3 million for Q4 2025, down 1286962260.0% quarter-over-quarter from -$5.0 in Q3 2025.

Medicus Pharma (MDCX) Retained Earnings (2023 - 2025) Analysis & Trends

Medicus Pharma has reported Retained Earnings for 2 years, with the latest figure at -$64.3 million in Q4 2025.

For the quarter ending Q4 2025, Retained Earnings changed N/A year-over-year to -$64.3 million; the trailing twelve-month figure through Dec 2025 stood at -$64.3 million (changed N/A YoY), and the FY2025 full-year result was -$64.3 million, changed N/A from the prior year.
Retained Earnings for Q4 2025 stood at -$64.3 million, down from -$5.0 in the prior quarter.
The five-year high for Retained Earnings was -$5.0 in Q3 2025, with the low at -$64.3 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Retained Earnings (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	1.90 Bn
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	29.51 Bn
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	-14.83 Bn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	-17.87 Bn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	66.72 Bn
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	-190.00 Mn
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	78.00 Mn
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	-7.20 Bn
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	-1.37 Bn
10	Medicus Pharma	6.05 Mn	6.15 Mn	-	-64.35 Mn

Download Data